5-methylcytosine has been researched along with Mycosis Fungoides in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, X; Lian, CG; Liu, F; Liu, X; Qiu, L; Tu, P; Wang, Y; Xiao, C; Yi, S | 1 |
Gambichler, T; Mamali, K; Moritz, R; Mucke, M; Patsinakidis, N; Skrygan, M; Stockfleth, E; Stücker, M | 1 |
2 other study(ies) available for 5-methylcytosine and Mycosis Fungoides
Article | Year |
---|---|
Loss of 5-Hydroxymethylcytosine Is an Epigenetic Biomarker in Cutaneous T-Cell Lymphoma.
Topics: 5-Methylcytosine; Apoptosis; Biomarkers, Tumor; Carcinogenesis; CD4-Positive T-Lymphocytes; Cell Line, Tumor; Disease Progression; Epigenesis, Genetic; Female; Humans; Keratinocytes; Lymphoma, T-Cell, Cutaneous; Male; Mycosis Fungoides; Neoplasm Staging; Prognosis; Skin Neoplasms; Survival Analysis | 2018 |
Decreased expression of ten-eleven translocation 2 protein is associated with progressive disease and death in patients with mycosis fungoides.
Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Biomarkers; Dioxygenases; Disease Progression; DNA-Binding Proteins; Female; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; Mycosis Fungoides; Proto-Oncogene Proteins; Skin Neoplasms | 2016 |